Thomson Reuters BONDplus
    EN : JP : CN : KR : ES : PT   



BONDplus: An integrated approach to biodiscovery
Thomson Reuters, the pre-eminent global information company, has acquired Unleashed Informatics and now administers and publishes the BOND database.

By integrating BOND with Scientific’s GENESEQ™, the definitive source of annotated biological sequences from worldwide patents, and the BINDplus (Biomolecular Interaction Network Database Plus) database, the largest manually-curated molecular interaction database available, BONDplus (Biomolecular Object Network Databank Plus) is able to take full account of all the relevant biological and IP relationships surrounding each molecule of interest.

No other resource integrates so much sequence, interaction, patent, taxonomy, publication, annotation, domain, and cross-reference data.

We will continue to provide an open access version of BOND, providing its subscribers with free, unlimited access to a core content set. But we are confident you will soon want to upgrade to BONDplus.

 

Contact us for more information.




In the News
BONDplus is a life science data platform that combines public and proprietary sequence, interaction and related interactome information to deliver powerful, integrated search results across vast pools of life science data. More...

----------------------------------

Thomson Reuters acquired Unleashed Informatics Limited in March 2007

BONDplus Login

BOND Login

Scientific Home   |   About Scientific   |   Site Search   |   Site Map
Copyright Notices   |   Terms of Use   |   Privacy Statement